NCT03995381

Brief Summary

Vascular closure device, hemostatic bandage and manual compression can achieve hemostasis after angiographic examination. These three methods of hemostasis changed the rate of hemostasis, early ambulation, hematoma , hemostasis failure rate, and expense. Therefore, shared decision making (SDM) is necessary to aid patients to choose hemostasis.The investigators have developed a decision aids (DA) and planned a randomized controlled trial (RCT) to evaluate its impact on angiographic patients. The measurements include a battery of interview-based questionnaires and evaluations of decision conflicts. The investigators expect the DAs would benefit the intervention group in the aspects of knowledge, communication and choice conflicts.during and after thier Hemostasis procedure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 21, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 24, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

September 19, 2019

Status Verified

June 1, 2019

Enrollment Period

1.3 years

First QC Date

June 21, 2019

Last Update Submit

September 17, 2019

Conditions

Keywords

Haemostasis

Outcome Measures

Primary Outcomes (1)

  • Decisional conflict

    Total score of decisional conflict scale

    1 hour before Angiography

Study Arms (2)

DAs group

EXPERIMENTAL

Shared decision making using decision aids

Other: Decision aids

Control group

NO INTERVENTION

Standard oral explanation guided with booklets

Interventions

Shared decision making with decision aids

DAs group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who needs an angiographic examination or treatment.
  • Patients with angiographic indications
  • Patients who were able to give consent and complete the interview

You may not qualify if:

  • The angiographic procedure uses patients with a catheter size more than 7fr.
  • Patients in critical situations requiring urgent treatment
  • Patients had cognitive impairment
  • Patients were physically unfit to be interviewed
  • Patients were non-Mandarin or -Taiwanese

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shuang Ho Hospital, Taipei Medical University

New Taipei City, Taiwan

Location

MeSH Terms

Interventions

Decision Support Techniques

Intervention Hierarchy (Ancestors)

Investigative Techniques

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2019

First Posted

June 24, 2019

Study Start

October 1, 2019

Primary Completion

December 31, 2020

Study Completion

December 31, 2021

Last Updated

September 19, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations